Equillium (EQ) Operating Leases (2021 - 2026)
Equillium's (EQ) quarterly Operating Leases came in at $251000.0 in Q1 2026, up 68.46% year-on-year from $149000.0 in Q1 2025, and down 29.49% on a QoQ basis from $356000.0 in Q4 2025.
Equillium (EQ) Operating Leases (2021 - 2026) Analysis & Trends
Equillium (EQ) has 6 years of Operating Leases data on file, last reported at $251000.0 in Q1 2026.
- On a quarterly basis, Operating Leases rose 68.46% year-over-year to $251000.0 in Q1 2026; TTM through Mar 2026 was $251000.0, a 68.46% increase from a year earlier, with the FY2025 full-year figure at $356000.0, up 90.37% from the prior year.
- Operating Leases for Q1 2026 stood at $251000.0, down from $356000.0 in the prior quarter.
- Over the last five years, Operating Leases for EQ reached as high as $1.1 million in Q1 2022 and fell as low as $109000.0 in Q2 2025.
- Historically, Operating Leases has averaged $494588.2 across 5 years, with a median of $384000.0 in 2023.
- Across the five-year window, Operating Leases plunged 58.97% in 2024 and surged 112.11% in 2025, its largest moves.
- Year by year, Operating Leases stood at $824000.0 in 2022, then plunged by 53.4% to $384000.0 in 2023, then sank by 51.3% to $187000.0 in 2024, then soared by 90.37% to $356000.0 in 2025, then fell by 29.49% to $251000.0 in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $251000.0 in Q1 2026, $356000.0 in Q4 2025, and $473000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 251,000.00 |
| Dec 31, 2025 | 356,000.00 |
| Sep 30, 2025 | 473,000.00 |
| Jun 30, 2025 | 109,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 187,000.00 |
| Sep 30, 2024 | 223,000.00 |
| Jun 30, 2024 | 259,000.00 |
| Mar 31, 2024 | 295,000.00 |
| Dec 31, 2023 | 384,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 609,000.00 |
| Mar 31, 2023 | 719,000.00 |
| Dec 31, 2022 | 824,000.00 |
| Sep 30, 2022 | 925,000.00 |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.24 Mn |